These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 33462316)

  • 1. GATA3 somatic mutations are associated with clinicopathological features and expression profile in TCGA breast cancer patients.
    Afzaljavan F; Sadr AS; Savas S; Pasdar A
    Sci Rep; 2021 Jan; 11(1):1679. PubMed ID: 33462316
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer-specific mutation of GATA3 disrupts the transcriptional regulatory network governed by Estrogen Receptor alpha, FOXA1 and GATA3.
    Takaku M; Grimm SA; De Kumar B; Bennett BD; Wade PA
    Nucleic Acids Res; 2020 May; 48(9):4756-4768. PubMed ID: 32232341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GATA3 mutations define a unique subtype of luminal-like breast cancer with improved survival.
    Jiang YZ; Yu KD; Zuo WJ; Peng WT; Shao ZM
    Cancer; 2014 May; 120(9):1329-37. PubMed ID: 24477928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance.
    Lu S; Yakirevich E; Wang LJ; Resnick MB; Wang Y
    BMC Cancer; 2019 Nov; 19(1):1085. PubMed ID: 31718619
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GATA3 mRNA expression, but not mutation, associates with longer progression-free survival in ER-positive breast cancer patients treated with first-line tamoxifen for recurrent disease.
    Liu J; Prager-van der Smissen WJ; Look MP; Sieuwerts AM; Smid M; Meijer-van Gelder ME; Foekens JA; Hollestelle A; Martens JW
    Cancer Lett; 2016 Jun; 376(1):104-9. PubMed ID: 27018307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of GATA3 expression in triple-positive breast cancer with overall survival and immune cell infiltration.
    Chen X; Zhao W; Huang Y; Luo S; Tang X; Yi Q
    Sci Rep; 2024 Aug; 14(1):17795. PubMed ID: 39090342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast tumor specific mutation in GATA3 affects physiological mechanisms regulating transcription factor turnover.
    Adomas AB; Grimm SA; Malone C; Takaku M; Sims JK; Wade PA
    BMC Cancer; 2014 Apr; 14():278. PubMed ID: 24758297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential expression of progesterone receptor, FOXA1, GATA3, and p53 between pre- and postmenopausal women with estrogen receptor-positive breast cancer.
    Hosoda M; Yamamoto M; Nakano K; Hatanaka KC; Takakuwa E; Hatanaka Y; Matsuno Y; Yamashita H
    Breast Cancer Res Treat; 2014 Apr; 144(2):249-61. PubMed ID: 24549642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GATA3 expression and its relationship with clinicopathological parameters in invasive breast carcinomas.
    Cakir A; Isik Gonul I; Ekinci O; Cetin B; Benekli M; Uluoglu O
    Pathol Res Pract; 2017 Mar; 213(3):227-234. PubMed ID: 28215639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and mutational analysis of GATA3 in Malaysian breast carcinomas.
    Bong PN; Zakaria Z; Muhammad R; Abdullah N; Ibrahim N; Emran NA; Syed Hussain SN
    Malays J Pathol; 2010 Dec; 32(2):117-22. PubMed ID: 21329183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of the effectiveness of GATA3 as a prognostic factor in breast cancer.
    Fararjeh AS; Tu SH; Chen LC; Liu YR; Lin YK; Chang HL; Chang HW; Wu CH; Hwang-Verslues WW; Ho YS
    Hum Pathol; 2018 Oct; 80():219-230. PubMed ID: 29902578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shift in GATA3 functions, and GATA3 mutations, control progression and clinical presentation in breast cancer.
    Cohen H; Ben-Hamo R; Gidoni M; Yitzhaki I; Kozol R; Zilberberg A; Efroni S
    Breast Cancer Res; 2014 Nov; 16(6):464. PubMed ID: 25410484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Common genetic variation in GATA-binding protein 3 and differential susceptibility to breast cancer by estrogen receptor alpha tumor status.
    Garcia-Closas M; Troester MA; Qi Y; Langerød A; Yeager M; Lissowska J; Brinton L; Welch R; Peplonska B; Gerhard DS; Gram IT; Kristensen V; Børresen-Dale AL; Chanock S; Perou CM
    Cancer Epidemiol Biomarkers Prev; 2007 Nov; 16(11):2269-75. PubMed ID: 18006915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic and clinicopathological value of GATA binding protein 3 in breast cancer: A systematic review and meta-analysis.
    Guo Y; Yu P; Liu Z; Maimaiti Y; Chen C; Zhang Y; Yin X; Wang S; Liu C; Huang T
    PLoS One; 2017; 12(4):e0174843. PubMed ID: 28394898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A transcriptional complex composed of ER(α), GATA3, FOXA1 and ELL3 regulates IL-20 expression in breast cancer cells.
    Lee JY; Park YJ; Oh N; Kwack KB; Park KS
    Oncotarget; 2017 Jun; 8(26):42752-42760. PubMed ID: 28514748
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GATA3 expression in advanced breast cancer: prognostic value and organ-specific relapse.
    McCleskey BC; Penedo TL; Zhang K; Hameed O; Siegal GP; Wei S
    Am J Clin Pathol; 2015 Nov; 144(5):756-63. PubMed ID: 26486740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA3 mutations found in breast cancers may be associated with aberrant nuclear localization, reduced transactivation and cell invasiveness.
    Gaynor KU; Grigorieva IV; Allen MD; Esapa CT; Head RA; Gopinath P; Christie PT; Nesbit MA; Jones JL; Thakker RV
    Horm Cancer; 2013 Jun; 4(3):123-39. PubMed ID: 23435732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Genetic Variants in GATA3 and Breast Cancer Treatment Outcomes in SWOG S8897 Trial and the Pathways Study.
    Larsen V; Barlow WE; Yang JJ; Zhu Q; Liu S; Kwan ML; Ergas IJ; Roh JM; Hutchins LF; Kadlubar SA; Albain KS; Rae JM; Yeh IT; Ravdin PM; Martino S; Lyss AP; Osborne CK; Hortobagyi GN; Kushi LH; Hayes DF; Ambrosone CB; Yao S
    Clin Breast Cancer; 2019 Aug; 19(4):225-235.e2. PubMed ID: 30928413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The significance of GATA3 expression in breast cancer: a 10-year follow-up study.
    Ciocca V; Daskalakis C; Ciocca RM; Ruiz-Orrico A; Palazzo JP
    Hum Pathol; 2009 Apr; 40(4):489-95. PubMed ID: 19084267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.